We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...

China and Indonesia signed agreements worth $10 billion during the Indonesia-China Business Forum, encompassing sectors like ...

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ ...

Do you use biotechnology on a daily basis? Your first reaction might be to say no. But what many people don’t realize is that ...

OpiAID’s platform technology is based on mutual trust between the ... and the deaths of neighbors. The North Carolina ...

Stay updated on Beam Therapeutics Inc.'s latest advancements in Sickle Cell Disease and alpha-1 antitrypsin deficiency treatments. Click for my BEAM stock update.

Attend Pittcon 2025 in Boston to connect with global leaders in laboratory science and explore cutting-edge advancements in ...

The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech ...

Modern warfare can kill more people in a shorter amount of time than at any point in history. Some of the most controversial ...

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is ...

Michael Sitzman joined McDermott Will & Emery as a partner in its intellectual property practice group in San Francisco, the firm announced Tuesday.

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...